A

Aptose Biosciences Inc
NASDAQ:APTO

Watchlist Manager
Aptose Biosciences Inc
NASDAQ:APTO
Watchlist
Price: 2.01 USD 17.54% Market Closed
Market Cap: 3.2m USD

Operating Margin
Aptose Biosciences Inc

0%
Current
0%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-36.2m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Aptose Biosciences Inc
Glance View

Market Cap
3.2m USD
Industry
Biotechnology

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. The company is headquartered in North York, Ontario and currently employs 41 full-time employees. The firm has two clinical-stage investigational products for hematologic malignancies: luxeptinib and APTO-253. The luxeptinib is a mutation agnostic Bruton’s tyrosine kinase (BTK) kinase inhibitor, which is in a Phase I a/b trial in patients with refractory B cell malignancies, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL) and non-Hodgkin lymphoma (NHL), who have failed or are intolerant to standard therapies and is in a separate Phase I a/b trial in patients with refractory acute myeloid leukemia (AML). Its APTO-253 is the clinical stage agent that directly targets the Master Regulator of Cell Cycle Entry and Proliferative Metabolism (MYC) oncogene and suppresses its expression, which is in a Phase I a/b clinical trial for the treatment of patients with relapsed.

APTO Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-36.2m
/
Revenue
0
What is the Operating Margin of Aptose Biosciences Inc?

Based on Aptose Biosciences Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top